2 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Not yet recruiting 1, Recruiting 1 |
Follow hydronidone: new trials by email Literature Review of hydronidone trials Research Report on hydronidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis Hydronidone Capsules - Chronic Hepatitis B With Hepatic Fibrosis | Phase 3 | Completed | Beijing Continent Pharmaceutical Co, Ltd. | 337 | 2026-03-16 | 2026-08-13 |
| A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B. Hydronidone (270mg), Hydronidone (Placebo Group) - Liver Fibrosis, Liver Fibrosis in Chronic Hepatitis B | Phase 3 | Not yet recruiting | Beijing Continent Pharmaceutical Co, Ltd. | 1208 | 2026-01-30 | 2026-02-17 |
| Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis Hydronidone capsules, The placebo capsules - Liver Fibrosis | Phase 3 | Recruiting | Beijing Continent Pharmaceutical Co, Ltd. | 248 | 2023-08-12 | 2025-06-04 |
| Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial. Hydronidone capsules, The placebo capsules - Liver Fibrosis | Phase 3 | Completed | Beijing Continent Pharmaceutical Co, Ltd. | 248 | 2021-12-30 | 2024-12-20 |
Liver Cirrhosis (3)
Beijing Continent Pharmaceutical Co, Ltd. (4)
China (4)
Jun Cheng, Dr (1) · Jun Cheng, Dr. (1) · Lungen Lu, Dr (1) · Lungen Lu, Dr. (1)